FOXP3 and breast cancer: As pDCs are the principal producers of IFN-α [51] to initiate innate immune responses, suboptimal IFN-α production promotes the expansion of FOXP3(+) regulatory T cells, leading to poor prognosis in breast cancer patients [52].